Adynxx, Inc. (ADYX) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 PINE ST., STE. 500
SAN FRANCISCO, CA 94111
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments247,7318,88011,09511,0211,536
Cash and cash equivalents247,7318,88011,09511,0211,536
Restricted cash and investments254     
Receivables  50341724424,029
Inventory, net of allowances, customer advances and progress billings  1101011831391,655
Inventory  1101011831391,655
Prepaid expense844     
Disposal group, including discontinued operation   604451,224217
Other current assets      6,062
Other undisclosed current assets778183226341180(5,901)
Total current assets:1,9008,0749,30112,23613,0067,598
Noncurrent Assets
Operating lease, right-of-use asset779 
Property, plant and equipment61662002793671,385
Intangible assets, net (including goodwill)      22,594
Goodwill      1,659
Intangible assets, net (excluding goodwill)      20,935
Disposal group, including discontinued operation, noncurrent assets  703    
Other noncurrent assets18178178178178173
Other undisclosed noncurrent assets  1,001    
Total noncurrent assets:8032,04837845754524,152
TOTAL ASSETS:2,70310,1229,67912,69313,55131,750
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,2286609495617582,875
Accounts payable1,7483955643055092,875
Accrued liabilities1,480265385256249 
Debt8,233    12,831
Derivative instruments and hedges, liabilities  291156186164149
Disposal group, including discontinued operation  242712,3512,300 
Other liabilities      8,149
Other undisclosed current liabilities      (3,024)
Total current liabilities:11,4619751,3763,0983,22220,980
Noncurrent Liabilities
Long-term debt and lease obligation493 515355295
Long-term debt, excluding current maturities   515355295
Liabilities, other than long-term debt  760    
Disposal group, including discontinued operation, liabilities  760    
Operating lease, liability493 
Other undisclosed noncurrent liabilities  1,001    
Total noncurrent liabilities:4931,761515355295
Total liabilities:11,9542,7361,4273,1513,27721,275
Equity
Equity, attributable to parent(9,251)7,3868,2529,54210,27410,475
Common stock655555
Additional paid in capital35,160166,674166,674166,674166,651165,590
Accumulated deficit(44,417)(159,293)(158,427)(157,137)(156,382)(155,120)
Total equity:(9,251)7,3868,2529,54210,27410,475
TOTAL LIABILITIES AND EQUITY:2,70310,1229,67912,69313,55131,750

Income Statement (P&L) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues421294603488645,381
Revenue, net5,381
Sublease income42 
Cost of revenue  (237)(349)(361)(593)(1,704)
Gross profit:42(108)111(13)2713,677
Operating expenses(2,245)(875)(1,487)(957)(1,476)(8,218)
Other undisclosed operating loss(42)     
Operating loss:(2,245)(983)(1,376)(970)(1,205)(4,541)
Nonoperating income (expense)  (123)42(14)(1,717)(566)
Investment income, nonoperating  1212841
Interest and debt expense(2,373)   (1,706)(548)
Loss from continuing operations before equity method investments, income taxes:(4,618)(1,106)(1,334)(984)(4,628)(5,655)
Other undisclosed income from continuing operations before income taxes     1,706548
Loss from continuing operations before income taxes:(4,618)(1,106)(1,334)(984)(2,922)(5,107)
Income tax expense (benefit)     3(3)
Loss from continuing operations:(4,618)(1,106)(1,334)(984)(2,919)(5,110)
Loss before gain (loss) on sale of properties:(4,618)(866)(1,232)(754)(6,783)(5,110)
Income (loss) from discontinued operations  240102230(3,864) 
Net loss:(4,618)(866)(1,232)(754)(6,783)(5,110)
Other undisclosed net income (loss) attributable to parent (58) (58) 5,521 
Net loss available to common stockholders, diluted:(4,676)(866)(1,290)(754)(1,262)(5,110)

Comprehensive Income ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net loss:(4,618)(866)(1,232)(754)(6,783)(5,110)
Comprehensive loss, net of tax, attributable to parent:(4,618)(866)(1,232)(754)(6,783)(5,110)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: